
WA clinicians flag cannabis-related mental-health risks and training gaps
A UW-led survey of 388 Washington clinicians (late 2024–early 2025) finds most view cannabis use as carrying mental-health risks, with 70% treating cannabis hyperemesis syndrome, 65% cannabis-use disorder, 63% anxiety, and 53% psychoses/hallucinations. Many respondents report only moderate knowledge about cannabis interactions and psychoses, and about 75% want more training on screening and managing cannabis-related health risks, highlighting the need for clearer treatment protocols amid provider shortages.













